Fresenius Kabi
News
August 8, 2022
Fresenius Kabi, a Leader in Injectable Medicines, Introduces Data Matrix Barcodes on all Drugs as part of Companywide Commitment to Medication Safety
read moreAugust 1, 2022
Fresenius Kabi’s Biologic License Application for Biosimilar Candidate Tocilizumab Accepted for Review in the U.S.
read moreJuly 29, 2022
Fresenius Kabi Announces U.S. Availability of Cancer Therapeutic Thiotepa
read moreJuly 25, 2022
Fresenius Kabi Expands Ready-to-Administer Portfolio with Glycopyrrolate Injection, USP Simplist® Prefilled Syringe
read moreJuly 18, 2022
Fresenius Kabi Introduces Generic Iodixanol Contrast Media Agent
read moreJuly 12, 2022
Romidepsin for Injection Available from Fresenius Kabi
read moreJune 14, 2022
Fresenius Kabi Expands RFID Compatibility to Improve Hospital Inventory Management
read moreMay 31, 2022
Fresenius Kabi Introduces PEMEtrexed for Injection, USP in the U.S.
read moreMay 18, 2022
Dr. Brandee Pappalardo Joins Fresenius Kabi as Chief Medical Officer for North America
read moreMay 4, 2022
Fresenius Kabi Completes Acquisition of Ivenix
read more
- August 9 - 12, 2022
- |
- Las Vegas, Nevada
NPPA: National Pharmacy Purchasing Association
Bally's Las Vegas, Nevada
- August 12 - 16, 2022
- |
- Chicago, IL
AANA: American Association of Nurse Anesthetists
Hyatt Regency Chicago, Chicago, IL
- August 16 - 18, 2022
- |
- Virtual Event
Oley Foundation 2022 Annual Meeting
- August 29 - 31, 2022
- |
- New York, New York
Magellan RX Specialty Summit
Magellan RX Specialty Summit, Sheraton New York Times Square Hotel
- September 7 - 9, 2022
- |
- Nashville, TN
APSF Stoelting Conference
Loews Vanderbilt Hotel Nashville, TN
